EXPANSION OF STUDY - Through private donations and politics
(As of April 6th, 2022)
We will continue to collect until the end of May 2022, also with the funding amount of €800,000 decided by Bavarian state politics on April 6th, 2022. We would like to thank you very much for this and with further donations we could implement some expansions of the study (e.g. further doses of the drug BC007 if the autoantibodies reappear, longer course of the study, extension of the follow-up observations, supplementation of examinations and follow-up examinations). We have already achieved a great deal and look forward to your donations, which we urgently need.
Many many thanks!
The #fundraisingbc007MEcfs team
For more information see the FAQ.
The first 100,000 Euros that are needed for the study at the Erlangen University Hospital for the treatment of ME/CFS: Alexander Graef, first chairman of the Brückeverbindet association (left), handing over the check to the molecular medicine specialist and ophthalmologist PD Dr. Dr. Bettina Hohberger and Prof. Dr. Werner G. Daniel (Chairman of the Board/Research Foundation Medicine). Photo: Kerstin Bönisch/ Erlangen University Hospital
Your money goes directly to our donation account at Berliner Sparkasse:
Brückeverbindet e.V. IBAN: DE43 1005 0000 0191 0769 61 BIC: BELADEBEXXX
In case of direct bank transfer please use the
Password „BC007 for ME/CFS“.
If the donation exceeds 200 €, please also include your e-mail and postal address for sending the donation receipt in the payment reference.
Your donation will be credited in full to the Brückeverbindet e.V. fundraisingBC007MEcfs account minus any fees incurred for the transfer. If the donation goal of at least €800,000 will not be reached, the amount you have donated will be credited back to you minus any fees incurred for the return transfer.